Clinical data analysis revealed a positive correlation between serum apelin levels and serum total triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels in these 74 MASLD patients (Fig. 1F). Here, APLN is linked to metabolic dysfunction-associated steatotic liver disease.